South Korea on Friday “strongly protested” Japan’s renewed claim that the disputed islets are "an inherent part" of its territory. The islets are “South Korea’s inherent territory in ...

First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce Insulin Without Immunosuppression Results ...

The study identified no safety issues, and the HIP-modified islet cells evaded immune responses. “These initial exciting results build upon the extensive preclinical and translational studies of ...

The Seattle-based biotech is evaluating UP421, a donor-derived allogeneic primary islet cell therapy, as a type 1 diabetes treatment that doesn’t require the use of any immunosuppression.

and new approaches in clinical evaluation including Sana Biotechnologies new islet replacement therapy. The FDA has approved 42 gene and cell therapies to date, addressing various diseases.

First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce Insulin Without Immunosuppression Results ...

Opens in a new tab or window Sana Biotechnology said a type 1 diabetes (T1D) patient received an allogeneic primary islet cell transplantation without immunosuppression. The company's engineered ...

Situated on the outskirts of the tourist resort area of Rodney Bay on the island's north-east coast, Beausejour Stadium is one of the Caribbean's newest major venues, completed in 2002 and staging ...

Workshops and sessions will also be organised to discuss diabetes foot, genetics, pancreatic and islet cell transplantation, body composition analysis, and insulin pump usage. Presentations and ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...